Converging technologies to enable induced pluripotent stem cells in drug discovery
Author:
Affiliation:
1. Fate Therapeutics, Inc., 3535 General Atomics Drive, Suite 200, San Diego, CA 92121, USA
2. Fate Therapeutics, Inc., 3535 General Atomics Drive, Suite 200, San Diego, CA 92121, USA.
Publisher
Future Medicine Ltd
Subject
Embryology,Biomedical Engineering
Link
https://www.futuremedicine.com/doi/pdf/10.2217/rme.10.48
Reference14 articles.
1. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2. Variation in the safety of induced pluripotent stem cell lines
3. Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
4. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
5. Induced Pluripotent Stem Cells Generated Without Viral Integration
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fresh Umbilical Cord Blood—A Source of Multipotent Stem Cells, Collection, Banking, Cryopreservation, and Ethical Concerns;Life;2023-08-23
2. Umbilical Cord Blood: A Trustworthy Source of Multipotent Stem Cells for Regenerative Medicine;Cell Transplantation;2014-05
3. Induced pluripotent stem cells: opportunities and challenges;Regenerative Medicine;2010-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3